Iqvia Holdings Inc. (IQV) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026
Summary
Iqvia’s revenue went from $6.9B in fiscal 2016 to $16.3B in fiscal 2025, growth of about 10.1% a year.
Net income in fiscal 2025 was $1.4B, a net margin of 8.3%; the best year in this period was 2024 with $1.4B.
Over the twelve months to September 30, 2026, revenue was $17.3B and net income $1.4B.
Free cash flow was $2.1B in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count rose 14% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.3B | $16.3B | $15.4B | $15.0B | $14.4B | $13.9B | $11.4B | $11.1B | $10.4B | $9.7B | $6.9B |
| Gross profit | — | — | — | — | — | — | — | — | — | $5.1B | $3.6B |
| Operating income | $2.2B | $2.2B | $2.2B | $2.0B | $1.8B | $1.4B | $731M | $777M | $741M | $665M | $576M |
| Net income | $1.4B | $1.4B | $1.4B | $1.4B | $1.1B | $966M | $279M | $191M | $259M | $1.3B | $72M |
| EPS (diluted) | $8.22 | $7.84 | $7.49 | $7.29 | $5.72 | $4.95 | $1.43 | $0.96 | $1.24 | $5.74 | $0.47 |
| R&D | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | +5.9% | +2.8% | +4.0% | +3.9% | +22.1% | +2.4% | +6.5% | +6.9% | +41.6% | +19.9% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.7B | $2.7B | $2.7B | $2.1B | $2.3B | $2.9B | $2.0B | $1.4B | $1.3B | $970M | $860M |
| Capital spending | -$657M | -$603M | -$602M | -$649M | -$674M | -$640M | -$616M | -$582M | -$459M | -$369M | -$164M |
| Free cash flow | $2.1B | $2.1B | $2.1B | $1.5B | $1.6B | $2.3B | $1.3B | $835M | $795M | $601M | $696M |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — |
| Buybacks | $1.2B | $1.2B | $1.4B | $992M | $1.2B | $406M | $447M | $949M | $1.4B | $2.6B | $1.1B |
| Stock-based pay | $303M | $247M | $206M | $217M | $194M | $170M | $95M | $146M | $113M | $106M | $106M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $2.1B | $1.8B | $1.5B | $1.3B | $1.5B | $1.9B | $899M | $938M | $1.0B | $1.2B |
| Debt | — | $16.1B | $14.3B | $14.1B | $13.2B | $12.6B | $13.1B | $12.3B | $11.1B | $10.3B | $7.2B |
| Equity | — | $6.5B | $6.1B | $6.1B | $5.8B | $6.0B | $6.0B | $6.0B | $6.7B | $8.0B | $8.6B |
| Total assets | — | $29.9B | $26.9B | $26.7B | $25.3B | $24.7B | $24.6B | $23.3B | $22.5B | $22.9B | $21.2B |
| Shares (diluted) | 167M | 174M | 183M | 186M | 191M | 195M | 195M | 200M | 208M | 223M | 152M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — | — | 52.5% | 52.9% |
| Operating margin | 12.8% | 13.4% | 14.3% | 13.2% | 12.5% | 10.0% | 6.4% | 7.0% | 7.1% | 6.8% | 8.4% |
| Net margin | 8.1% | 8.3% | 8.9% | 9.1% | 7.6% | 7.0% | 2.5% | 1.7% | 2.5% | 13.1% | 1.1% |
| FCF margin | 12.0% | 12.6% | 13.7% | 10.0% | 11.0% | 16.6% | 11.8% | 7.5% | 7.6% | 6.2% | 10.1% |
| ROIC | — | 8.1% | 8.8% | 9.1% | 7.7% | 6.4% | 3.1% | 2.9% | 3.4% | 2.9% | 2.9% |
| ROE | — | 20.9% | 22.6% | 22.2% | 18.9% | 16.0% | 4.7% | 3.2% | 3.9% | 16.0% | 0.8% |
Frequently asked questions
What is Iqvia’s annual revenue?
$16.3B in fiscal 2025 and $17.3B over the twelve months to September 30, 2026.
How much profit does Iqvia make?
Net income was $1.4B in fiscal 2025 (net margin 8.3%).
Is Iqvia’s revenue growing?
Yes: revenue rose 5.9% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.